Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Glenmark Pharma Appoints President North America | Contract Pharma
Breaking News, Promotions & Moves

Glenmark Pharma Appoints President North America

Gioia brings 25 years of industry experience

Philip Andrew Gioia has been appointed president North America and Global API business at Glenmark Pharmaceuticals. Mr. Gioia will be responsible for the generics and branded business across North America and also Global API sales and marketing. Mr. Gioia will be based in Mahwah, NJ and will report to Glenn Saldanha, chairman and managing director. He brings more than 25 years of experience in the U.S. pharmaceutical industry.
 
Mr. Gioia joins the company from Bausch & Lomb (acquired by Valeant Pharmaceuticals), where he most recently served as global head of diversified products and business development, Pharmaceuticals. Prior to that, he was division head of the Pharmaceutical Business Unit, North America, responsible for all aspects of P&L management, in addition to overall strategic commercial operations for the brand, generic and OTC divisions.
 
Prior to Bausch & Lomb, he spent 13 years at Barr Pharmaceuticals in roles of increased responsibility, including vice president and senior vice president of sales, and senior vice president of the $1.6 billion U.S. Generic Sales & Marketing business. He also led the forecasting group and was involved in product selection, planning, and logistics.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters